Description of Collaborative Activity: |
The Pediatric Formulations Initiative (PFI) is designed to look at all the factors that affect the development of pediatric drugs. The goals are to create a roadmap for removing/mitigating barriers to pediatric drug development and to connect researchers and experts in pediatric formulation to discuss issues and challenges that may stimulate further research in the field. This working group examined the application of the BCS and BDDS to pediatric medicines and addresses knowledge gaps in absorption, distribution, metabolism, and excretion (ADME) at different developmental stages. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
